Roselabs Finance Ltd — Board Meeting, 18-07-2025: Board Meeting

Roselabs Finance's board has approved its unaudited financial results for the quarter ended June 30, 2025. For this quarter, the company reported total expenses of ₹0.05 Cr, leading to a loss of ₹0.05 Cr. Earnings per share (EPS) stood at ₹(0.05). The statutory auditors, MSKA & Associates, issued an unmodified opinion on these results. Additionally, the board has fixed September 26, 2025, as the date for the 31st Annual General Meeting. This update provides key financial performance for the quarter and important shareholder meeting details.